Why the study?
Does prophylactic colchicine prevent postablation chest pain, pericarditis, and other complications in patients undergoing high-power short-duration ablation for atrial fibrillation?
Does prophylactic colchicine prevent postablation chest pain, pericarditis, and other complications in patients undergoing high-power short-duration ablation for atrial fibrillation?
Prophylactic colchicine does not provide additional advantage after high-power short-duration AF ablation and is associated with significant diarrhea.
Answers are grounded in this paper and cite their sources.
No support for prophylactic colchicine after AF ablation; leaves open confirmation by randomized trials while noting diarrhea risk.
In this single-operator retrospective analysis, prophylactic colchicine was not associated with significant reduction in the incidence of postablation chest pain, pericarditis, 30 day hospitalization, ER visits, or AF recurrence or need of cardioversion within first 30 days after HPSD ablation for AF. However, its usage was associated with significant diarrhea. This study concludes no additional advantage of prophylactic use of colchicine after HPSD AF ablation.
No takes yet. Share an insight, caveat, or question.
Iqbal et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: